Axtria Inc.

Axtria Inc. Axtria is a global provider of cloud software and data analytics to the Life Sciences industry.

The biggest barrier to digital clinical trials isn't technology. It's adopting the right technology for every site.At DP...
09/04/2026

The biggest barrier to digital clinical trials isn't technology. It's adopting the right technology for every site.

At DPHARM: Disruptive Innovations to Modernize Clinical Trials 2026, Joe Dustin, Senior Director, Digital Clinical Development at Sanofi and Denise Godel, Director, Clinical Solutions at Axtria will share how Sanofi is challenging traditional eSource assumptions with a site-centric BYOT approach designed to reduce friction, improve adoption, and maintain data quality at scale.

🎤Session: Sites in the Driver's Seat: How Sanofi Is Flipping the eSource Playbook

Explore:

• Why EHR-first strategies often miss the realities of site operations

• How BYOT enables flexible, scalable clinical data acquisition

• The organizational shifts required to support new operating models

• Lessons learned from early-phase implementation

📍The Sheraton Boston | September 15-16

See you there!

Learn more: https://hubs.la/Q04wJs7R0

Traditional master data management approach is good at flagging problems. Match queues grow, DCRs age, and confidence sc...
09/04/2026

Traditional master data management approach is good at flagging problems. Match queues grow, DCRs age, and confidence scores still land on a steward's desk for a judgment call.

The result is a widening gap between how fast data flows in and how fast it can be trusted. Stewards spend more time triaging low-risk decisions than resolving the ones that actually need their expertise, backlogs compound, and "high-quality master data" becomes a moving target instead of a steady state.

Agentic AI closes that gap by reasoning through the queue itself, not just scoring records, but understanding context, prioritizing what truly needs human judgment, and clearing the rest on its own.

Join us for an insightful webinar, "From Rules to Reasoning: Agentic AI for Next-Gen MDM in Pharma," to explore how agentic AI is enriching master data quality and accelerating speed to resolution with reasoning agents that work alongside stewards to enrich and match data intelligently beyond static rules, and to triage, recommend, and auto-resolve low-risk match conflicts and DCRs with humans in control of the judgment calls.

Featuring:

🎙️ Somy Silvy, Sr. Director, Data Strategy & Products, Johnson & Johnson Innovative Medicine
🎙️ Harneet Kapil, Principal, Data & AI, Axtria

Register now and get a live look at Axtria's Agentic MDM capabilities and a practical roadmap for AI adoption.: https://hubs.la/Q04wHyS40

📢1,000 seats. One job: make AI work where it delivers patient outcomes.💼Axtria's Forward Deployed Engineering team is sc...
09/03/2026

📢1,000 seats. One job: make AI work where it delivers patient outcomes.
💼Axtria's Forward Deployed Engineering team is scaling to 1,000 engineers by December 2026 and we're looking for people who'd rather build inside a client's toughest data environment than sit behind a demo.

FDEs don't ship features. They ship outcomes - production AI running across commercial, medical, and market access functions, inside the world's largest life sciences companies.

If you're certified (or want to be) across Anthropic, AWS, Databricks, LangChain, Microsoft, or Snowflake, and you'd rather solve real enterprise problems than theoretical ones, this is the team.

Build. Deploy. Transform. Be an FDE.

Apply now: https://hubs.la/Q04wv2hl0

  Your MDM can flag a potential match conflict. But can it reason through it? Traditional MDM systems rely on rules, con...
09/02/2026

Your MDM can flag a potential match conflict. But can it reason through it? Traditional MDM systems rely on rules, confidence scores, and steward intervention to manage growing volumes of complex data. As match queues expand and DCRs pile up, organizations need a smarter approach.

Join 🎙️Somy Silvy, Sr. Director, Data Strategy & Products, Johnson & Johnson Innovative Medicine and🎙️Harneet Kapil, Principal, Data & AI, Axtria for an insightful discussion on how Agentic AI is transforming Pharma MDM through reasoning-based agents that can:

✅ Enrich and match data beyond static rules

✅ Triage and prioritize DCRs intelligently

✅ Recommend actions for faster resolution

✅ Auto-resolve low-risk cases while maintaining governance

✅ Free stewards to focus on high-value decisions

Plus, see Axtria's Agentic MDM capabilities in action and learn a practical path to AI adoption.

Register here: https://hubs.la/Q04wfCF40

The next generation of clinical trials will be data-driven, AI-enabled, and patient-centric. At DPHARM: Disruptive Innov...
08/31/2026

The next generation of clinical trials will be data-driven, AI-enabled, and patient-centric. At DPHARM: Disruptive Innovations to Modernize Clinical Trials 2026, Axtria leaders will be joining industry peers to discuss the innovations transforming clinical development.

Meet our team:

✅ Heather Marino, Sr. Director, Digital Transformation and R&D

✅ Denise Godel, Director, R&D Product Strategy and Delivery

✅ Jo-Zahn Baxter, Director, Digital Transformation and R&D

If you're attending DPHARM, let's connect to explore how data, AI, and advanced analytics can help streamline clinical operations and accelerate better patient outcomes.

📍Boston | September 15-16

Learn more: https://hubs.la/Q04vWl7D0

As therapies increasingly expand across multiple indications, traditional pricing, reimbursement, and HTA frameworks are...
08/31/2026

As therapies increasingly expand across multiple indications, traditional pricing, reimbursement, and HTA frameworks are being pushed beyond their original design.

Our latest white paper explores the challenges and opportunities created by the rise of multi-indication therapies and outlines potential pathways for supporting innovation while improving patient access.

Download the paper to learn more. https://hubs.la/Q04vWhXK0

📢We just made one of the biggest calls in our company's history. Axtria is scaling its 💼Forward Deployed Engineering tea...
08/26/2026

📢We just made one of the biggest calls in our company's history. Axtria is scaling its 💼Forward Deployed Engineering team to 1,000 people by December 2026 globally. That makes it the largest pharma-specific AI engineering team anywhere in the industry.

This isn't a new experiment. It's the team that's already been building and deploying production AI systems inside our biggest pharma clients, growing to meet demand we didn't fully see coming ourselves.

Build. Deploy. Transform. Be an FDE.

🤝Learn more: https://hubs.la/Q04vms130

📢 We're heading to DPHARM: Disruptive Innovations to Modernize Clinical Trials 2026! Axtria is pleased to participate as...
08/25/2026

📢 We're heading to DPHARM: Disruptive Innovations to Modernize Clinical Trials 2026! Axtria is pleased to participate as an Associate Sponsor at the upcoming DPHARM Conference, bringing together more than 1,000 clinical research leaders, innovators, and industry experts focused on transforming the future of clinical trials.

If you're attending, connect with our team to discuss:
✅ AI-powered clinical development strategies
✅ Advanced analytics for trial optimisation
✅ Data-driven decision-making across the clinical lifecycle
✅ Accelerating innovation in life sciences

Let's connect and discuss how AI and analytics can help modernize clinical development and accelerate better outcomes.

📍 Boston | September 15-16

Learn more: https://hubs.la/Q04v9WNY0

One therapy. Multiple indications. Growing complexity.Multi-indication therapies are transforming treatment across oncol...
08/19/2026

One therapy. Multiple indications. Growing complexity.
Multi-indication therapies are transforming treatment across oncology, immunology, metabolic disease, and rare diseases, but current reimbursement and assessment frameworks often struggle to recognize their full value.

Explore practical strategies, global policy considerations, and future-ready approaches in our latest white paper.

Download the white paper: https://hubs.la/Q04tx_Dr0

08/19/2026

The HURUN Global Unicorn Index 2026 has recognized Axtria as one of the world's 30 Data & Analytics unicorns, placing us among a select group of companies shaping the future of data-driven innovation.

Published by the Hurun Research Institute, the Global Unicorn Index is a prestigious ranking of privately held startups founded in the 2000s with valuations exceeding $1 billion. This recognition reflects Axtria's continued commitment to helping life sciences organizations transform commercial operations through data, analytics, and AI-powered innovation.

Learn more: https://hubs.la/Q04tw6rk0

Address

Berkeley Heights, NJ

Opening Hours

Monday 8am - 6pm
Tuesday 8am - 6pm
Wednesday 8am - 6pm
Thursday 8am - 6pm
Friday 8am - 5pm

Telephone

+18779298742

Alerts

Be the first to know and let us send you an email when Axtria Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Axtria Inc.:

Shortcuts

Share